SlideShare a Scribd company logo
1 of 2
EstablishingandEvaluatingaPharmaceutical Care inRenal TransplantationClinicandthe Integrated
PharmaCloudService forPharmacistProfessionalPerformance
Authors Wang,Hue-Yu
http://www.airitilibrary.com/Publication/alDetailedMesh1?DocID=U0011-2411201600293900
KMUIR > College of Pharmacy > Graduate Institute of Pharmaceutical Sciences >Theses > Item
310902000/40198
References 87
unitiesandresponsibilitiesinpharmaceutical care.AmericanJournal of
Hospital Pharmacy.1990;47: 533-543.
譚延輝.藥事照護在台灣.藥學雜誌.2011;27:42-45.
KohnLT, editor.AcademicHealthCenters:LeadingChange inthe 21st Century.Washington(DC):National
AcademiesPress(US);2004. EXECUTIVE SUMMARY. 2004;
http://www.ncbi.nlm.nih.gov/books/NBK221671/.AccessedNov11, 2015
gnaG, Nili-AhmadabadiB.PharmacistCognitive Service andPharmaceutical
Care:Todayand TomorrowOutlook.UKJournal of Pharmaceutical andBiosciences.2015;3:67-72.
Model.
2008 ver.2;http://www.pharmacist.com/sites/default/files/files/core_elements_of_an_mtm_practice.pdf.
-----------------------------------------------------------------------------------------------------------------------------------------------
--
Background:To preventdrug-relatedproblemsinadvance andthusensure patientsafetyiscloselyrelated
to properpharmaceutical care andeffective model forpharmaceutical care.Atthe moment,OPD
pharmaceutical consultationisprovidedaccordingtophysicians’ordersandpatients’need.However,
proactive pharmaceutical care istobe initiatedandofferedbypharmaciststointerview face-to-face the
patients,discoverdrug-relatedproblems,provide withtherapyrecommendations,andinstructthe patients
howto take the medicinesproperly.Togetherwithwellrecordsof pharmaceutical care anddocumentsfor
drug-relatedproblems,greaterprofessionalismof pharmacistswouldbe demonstrated.
Objective:The studyaimstoestablishamodel of proactive pharmaceutical care basedondataon the NHI
PharmaCloudandhastwo objectives.First,toevaluate if persistentinfectiousdiarrheaisarisk factorfor
deteriorationof renal functioninkidneytransplantrecipients.Secondly,toanalyze the dataregarding the
prevalence andtypesof drug-relatedproblems(DRPs) andthe recommendationsforoptimizingmedication
providedbyclinical pharmacistsaftertwostages(Firststage (FS):pharmacistsreviewedthe datareal-time
and recordedthe DRPs;Secondstage (SS):pharmacistsreviewedandevaluatedthe pre-downloaded
patientprescriptiondataandrecordedall the DRPs) of implementationof NHIPharmaCloudSystem.
Methods:A cross-sectionalprospectivestudywasconductedata medical centerinSouthernTaiwan.In the
firstpart of the study,a retrospective andobservational studywasconductedusingHyperinDatabase of
the hospital.Patientswerecollectedaccordingtodiagnosesof diarrhea,diarrheaperiod≥3 days,use (or
not) of antibioticagents.Studentt-testsorANOVA were usedtoverifythe correlationamongthe serum
creatinine changesanddiarrheacauses,diarrheaperiods(continuousvariables).Inthe secondpartof the
study,data are presentedasmeanswithstandarddeviationsforcontinuousvariables andnumberswithfor
categorical variables.Drug-relatedproblemswereprobedandencodedwithAABBCCandrecorded
accordingto PCNE DRP v6.2 guideline (Pharmaceutical Care NetworkEurope WorkinggrouponDRPs).
Wilcoxonsigned-ranktestforcontinuousvariablesandPearson'sChi-square testorFisher'sexacttestfor
categorical variableswasusedtocompare the differencesbetweentwogroups.The logisticregressionwas
usedto estimate the associationbetweeneachdrug-relatedproblemsandstages.The multivariable logistic
regressioncalculatedthe oddsratios(ORs) and95% confidence intervals(CIs)afteradjustingpotential
confoundingfactors.Significance wassetatp< 0.05. All analyseswere presentedusingStatisticalAnalysis
System(SAS) statisticalsoftware (version9.4;SASInstitute,Inc,Cary,NC).
Resultsanddiscussion:The preliminaryresultsof the firstpartof the studyrevealedthatinkidney
transplantrecipients,patientswithinfectiousdiarrheademonstratedalargermeanserumcreatinine (Scr)
change than those withnon-infectiousdiarrhea(0.31±0.52 vs.0.1±0.27), and whentheirdiarrheapersisted
for more than 10 days,a significantlargermeanserumcreatinine change wouldbe observed(0.53±0.55 vs.
0.05±0.22; comparedwiththose withdiarrheaperiodof <10 days,p=0.0018), showingthatthe irreversible
kidneyallograftfunctionchange wasassociatedwithbothpersisteddiarrheaandinfectiousdiarrhea.
Besides,the immunosuppressive combinationof tacrolimus(TAC) andmycophenolate mofitil (MMF) might
be associatedwithanincreasedriskof noninfectiousdiarrhea.
The resultsof the secondpart of the studyrevealedthat“Treatmenteffectiveness”(Untreatedindication;
50.0%) was the mainprobleminthe FS groupand “Patient”(Patientforgetstouse/take drug;55.0%) inthe
SS group.Furtheranalysesof logisticregressionsrevealedthatpatientsinthe SSgrouphad a 2.7 timesof
riskto receive “Unnecessarydrug-treatment(P3.2)”than theydidinFS group(OR 2.7; p<0.0001) indicating
that the prescriptiondatadownloadedinbatchesfromthe PharmaCloudSystemcouldbe helpful for
clinical pharmaciststoidentifyDRPsmore efficientlywithsignificantclinicalbenefits.Onclassificationof
the drug-relatedproblems,“Treatmenteffectiveness”(41.3%) wasthe mostfrequentlyseenprobleminthe
FS groupand “Treatmentcost” (48.3%) in the SS group,and furtheranalysesdemonstratedthat
“Unnecessarydrugtreatment”wasthe mainproblemforall patients.Onthe cause of the problems,“Drug
selection”became the maincause forall the problems.
Thisstudydemonstratedthatthe PharmaCloudSystemallowedprescriptioninformationof patientstobe
sharedacross hospitalsandenabledpharmacistsandphysicianstoreview andevaluatemedicationsin
advance.The potential problemsof “Unnecessarydrugtreatment”andthe treatmentcostderivedfrom
that wouldbe resolvedefficiently.
Conclusion:Ourstudybringsnewdatainthe directionshowingthatinfectiousdiarrheadoesmore
damagesto renal functionthannon-infectiousonesinkidneytransplantrecipients,especiallywhenthe
diarrheapersistsformore than10 days.Our studyalso demonstratedthathigherefficiencyof the use of
the proactive model of pharmaceutical care waseasilyachievedtopreventand/orsolvedrug-related
problemsinadvance withPharmaCloudsystemessedNov11,2015

More Related Content

What's hot

Challenges and Solutions in Immune-Mediated Inflammatory Disease Trials White...
Challenges and Solutions in Immune-Mediated Inflammatory Disease Trials White...Challenges and Solutions in Immune-Mediated Inflammatory Disease Trials White...
Challenges and Solutions in Immune-Mediated Inflammatory Disease Trials White...Covance
 
FINAL POSTER- Research
FINAL POSTER- Research FINAL POSTER- Research
FINAL POSTER- Research Paige Dickey
 
Whitepaper: zekerheid over het juiste monster binnen de toenemende complexite...
Whitepaper: zekerheid over het juiste monster binnen de toenemende complexite...Whitepaper: zekerheid over het juiste monster binnen de toenemende complexite...
Whitepaper: zekerheid over het juiste monster binnen de toenemende complexite...Salm en Kipp bv Laboratoriumapparatuur
 
Guideline for the treatment of rheumatoid arthritis 2015
Guideline for the treatment of rheumatoid arthritis 2015Guideline for the treatment of rheumatoid arthritis 2015
Guideline for the treatment of rheumatoid arthritis 2015Jose Enrique Acharam Pacheco
 
CQRA PREMS NON-RA RHEUMATIC CONDITIONS BSR 2014 POSTER (1)
CQRA PREMS NON-RA RHEUMATIC CONDITIONS BSR 2014 POSTER (1)CQRA PREMS NON-RA RHEUMATIC CONDITIONS BSR 2014 POSTER (1)
CQRA PREMS NON-RA RHEUMATIC CONDITIONS BSR 2014 POSTER (1)Alison Elliott
 
public health _03302015 resized
public health _03302015 resizedpublic health _03302015 resized
public health _03302015 resizedZakkoyya Lewis
 
Accelerating development and approval of targeted cancer therapies
Accelerating development and approval of targeted cancer therapiesAccelerating development and approval of targeted cancer therapies
Accelerating development and approval of targeted cancer therapiesNational Institute of Biologics
 
Do we-have-the-right-dose-dose-adjustments-for-organ-dysfunction-2167-7700.10...
Do we-have-the-right-dose-dose-adjustments-for-organ-dysfunction-2167-7700.10...Do we-have-the-right-dose-dose-adjustments-for-organ-dysfunction-2167-7700.10...
Do we-have-the-right-dose-dose-adjustments-for-organ-dysfunction-2167-7700.10...science journals
 
Hematology Nurses Prefer more Subcutaneous Compared to Intravenous Administra...
Hematology Nurses Prefer more Subcutaneous Compared to Intravenous Administra...Hematology Nurses Prefer more Subcutaneous Compared to Intravenous Administra...
Hematology Nurses Prefer more Subcutaneous Compared to Intravenous Administra...Aleksandar Smokovski, MD
 
NURS 411_Codi_Leggett Assignment 6
NURS 411_Codi_Leggett Assignment 6NURS 411_Codi_Leggett Assignment 6
NURS 411_Codi_Leggett Assignment 6Codi Leggett
 
Time for Quality Measures to Get Personal
Time for Quality Measures to Get PersonalTime for Quality Measures to Get Personal
Time for Quality Measures to Get PersonalChristine Winters
 
EWMA 2013 - Ep546 - The impact of implementing evidence standardized wound as...
EWMA 2013 - Ep546 - The impact of implementing evidence standardized wound as...EWMA 2013 - Ep546 - The impact of implementing evidence standardized wound as...
EWMA 2013 - Ep546 - The impact of implementing evidence standardized wound as...EWMAConference
 
PEPTIC (Holden Young - Roseman University College of Pharmacy)
PEPTIC (Holden Young - Roseman University College of Pharmacy)PEPTIC (Holden Young - Roseman University College of Pharmacy)
PEPTIC (Holden Young - Roseman University College of Pharmacy)HoldenYoung3
 

What's hot (19)

2005 Cancer SOS paper
2005 Cancer SOS paper2005 Cancer SOS paper
2005 Cancer SOS paper
 
AMSN CHG poster 2015 Vegas Presentation
AMSN CHG poster 2015 Vegas PresentationAMSN CHG poster 2015 Vegas Presentation
AMSN CHG poster 2015 Vegas Presentation
 
Challenges and Solutions in Immune-Mediated Inflammatory Disease Trials White...
Challenges and Solutions in Immune-Mediated Inflammatory Disease Trials White...Challenges and Solutions in Immune-Mediated Inflammatory Disease Trials White...
Challenges and Solutions in Immune-Mediated Inflammatory Disease Trials White...
 
FINAL POSTER- Research
FINAL POSTER- Research FINAL POSTER- Research
FINAL POSTER- Research
 
Whitepaper: zekerheid over het juiste monster binnen de toenemende complexite...
Whitepaper: zekerheid over het juiste monster binnen de toenemende complexite...Whitepaper: zekerheid over het juiste monster binnen de toenemende complexite...
Whitepaper: zekerheid over het juiste monster binnen de toenemende complexite...
 
Guideline for the treatment of rheumatoid arthritis 2015
Guideline for the treatment of rheumatoid arthritis 2015Guideline for the treatment of rheumatoid arthritis 2015
Guideline for the treatment of rheumatoid arthritis 2015
 
CRR publication
CRR publicationCRR publication
CRR publication
 
the GRImP protocol
the GRImP protocolthe GRImP protocol
the GRImP protocol
 
CQRA PREMS NON-RA RHEUMATIC CONDITIONS BSR 2014 POSTER (1)
CQRA PREMS NON-RA RHEUMATIC CONDITIONS BSR 2014 POSTER (1)CQRA PREMS NON-RA RHEUMATIC CONDITIONS BSR 2014 POSTER (1)
CQRA PREMS NON-RA RHEUMATIC CONDITIONS BSR 2014 POSTER (1)
 
public health _03302015 resized
public health _03302015 resizedpublic health _03302015 resized
public health _03302015 resized
 
Edelman - Clinical Trials
Edelman - Clinical TrialsEdelman - Clinical Trials
Edelman - Clinical Trials
 
Accelerating development and approval of targeted cancer therapies
Accelerating development and approval of targeted cancer therapiesAccelerating development and approval of targeted cancer therapies
Accelerating development and approval of targeted cancer therapies
 
Agreeing what outcomes to measure
Agreeing what outcomes to measureAgreeing what outcomes to measure
Agreeing what outcomes to measure
 
Do we-have-the-right-dose-dose-adjustments-for-organ-dysfunction-2167-7700.10...
Do we-have-the-right-dose-dose-adjustments-for-organ-dysfunction-2167-7700.10...Do we-have-the-right-dose-dose-adjustments-for-organ-dysfunction-2167-7700.10...
Do we-have-the-right-dose-dose-adjustments-for-organ-dysfunction-2167-7700.10...
 
Hematology Nurses Prefer more Subcutaneous Compared to Intravenous Administra...
Hematology Nurses Prefer more Subcutaneous Compared to Intravenous Administra...Hematology Nurses Prefer more Subcutaneous Compared to Intravenous Administra...
Hematology Nurses Prefer more Subcutaneous Compared to Intravenous Administra...
 
NURS 411_Codi_Leggett Assignment 6
NURS 411_Codi_Leggett Assignment 6NURS 411_Codi_Leggett Assignment 6
NURS 411_Codi_Leggett Assignment 6
 
Time for Quality Measures to Get Personal
Time for Quality Measures to Get PersonalTime for Quality Measures to Get Personal
Time for Quality Measures to Get Personal
 
EWMA 2013 - Ep546 - The impact of implementing evidence standardized wound as...
EWMA 2013 - Ep546 - The impact of implementing evidence standardized wound as...EWMA 2013 - Ep546 - The impact of implementing evidence standardized wound as...
EWMA 2013 - Ep546 - The impact of implementing evidence standardized wound as...
 
PEPTIC (Holden Young - Roseman University College of Pharmacy)
PEPTIC (Holden Young - Roseman University College of Pharmacy)PEPTIC (Holden Young - Roseman University College of Pharmacy)
PEPTIC (Holden Young - Roseman University College of Pharmacy)
 

Similar to Establishing a Pharmaceutical Care Model and Evaluating Drug-Related Problems in Renal Transplant Patients

Risk factors for readmission after elective colectomy postoperative complica...
Risk factors for readmission after elective colectomy  postoperative complica...Risk factors for readmission after elective colectomy  postoperative complica...
Risk factors for readmission after elective colectomy postoperative complica...Gastroenterologia Medica Sur
 
roleofhospitalpharmacistsintransitionsofcare-130301172100-phpapp01 (1).pdf
roleofhospitalpharmacistsintransitionsofcare-130301172100-phpapp01 (1).pdfroleofhospitalpharmacistsintransitionsofcare-130301172100-phpapp01 (1).pdf
roleofhospitalpharmacistsintransitionsofcare-130301172100-phpapp01 (1).pdfssuser497f37
 
modified nutritional risk assessment score c.pptx
modified nutritional risk assessment score c.pptxmodified nutritional risk assessment score c.pptx
modified nutritional risk assessment score c.pptxDrSrinivasJayanthur
 
5_6142969729217726658-1.pdf
5_6142969729217726658-1.pdf5_6142969729217726658-1.pdf
5_6142969729217726658-1.pdfBrenoMoura21
 
Contents lists available at ScienceDirectApplied Nursing R
Contents lists available at ScienceDirectApplied Nursing RContents lists available at ScienceDirectApplied Nursing R
Contents lists available at ScienceDirectApplied Nursing RAlleneMcclendon878
 
Webinar: Defeating Superbugs: Hospitals on the Front Lines
Webinar: Defeating Superbugs: Hospitals on the Front Lines Webinar: Defeating Superbugs: Hospitals on the Front Lines
Webinar: Defeating Superbugs: Hospitals on the Front Lines Modern Healthcare
 
Healthcare transition.pptx
Healthcare transition.pptxHealthcare transition.pptx
Healthcare transition.pptxRafaelRios933315
 
Fletcher et al-2013-pediatric_blood_&amp;_cancer
Fletcher et al-2013-pediatric_blood_&amp;_cancerFletcher et al-2013-pediatric_blood_&amp;_cancer
Fletcher et al-2013-pediatric_blood_&amp;_cancermayagomez7
 
Fletcher et al-2013-pediatric_blood_&amp;_cancer
Fletcher et al-2013-pediatric_blood_&amp;_cancerFletcher et al-2013-pediatric_blood_&amp;_cancer
Fletcher et al-2013-pediatric_blood_&amp;_cancerisabelerazochaves
 
Goal directed resuscitation for patients
Goal directed resuscitation for patientsGoal directed resuscitation for patients
Goal directed resuscitation for patientsDrJawad Butt
 
Quality indicators for prevention and management of pressure ulcers
Quality indicators for prevention and management of pressure ulcersQuality indicators for prevention and management of pressure ulcers
Quality indicators for prevention and management of pressure ulcersGNEAUPP.
 
Quality in Critical Care_١١٣١٠١.pptx
Quality in Critical Care_١١٣١٠١.pptxQuality in Critical Care_١١٣١٠١.pptx
Quality in Critical Care_١١٣١٠١.pptxBassam411094
 
Impactof en feeding protocols
Impactof en feeding protocolsImpactof en feeding protocols
Impactof en feeding protocolsMario Sanchez
 

Similar to Establishing a Pharmaceutical Care Model and Evaluating Drug-Related Problems in Renal Transplant Patients (20)

CAUTI Article
CAUTI ArticleCAUTI Article
CAUTI Article
 
Risk factors for readmission after elective colectomy postoperative complica...
Risk factors for readmission after elective colectomy  postoperative complica...Risk factors for readmission after elective colectomy  postoperative complica...
Risk factors for readmission after elective colectomy postoperative complica...
 
ABO_LAVH
ABO_LAVHABO_LAVH
ABO_LAVH
 
DH_Publications
DH_PublicationsDH_Publications
DH_Publications
 
roleofhospitalpharmacistsintransitionsofcare-130301172100-phpapp01 (1).pdf
roleofhospitalpharmacistsintransitionsofcare-130301172100-phpapp01 (1).pdfroleofhospitalpharmacistsintransitionsofcare-130301172100-phpapp01 (1).pdf
roleofhospitalpharmacistsintransitionsofcare-130301172100-phpapp01 (1).pdf
 
modified nutritional risk assessment score c.pptx
modified nutritional risk assessment score c.pptxmodified nutritional risk assessment score c.pptx
modified nutritional risk assessment score c.pptx
 
5_6142969729217726658-1.pdf
5_6142969729217726658-1.pdf5_6142969729217726658-1.pdf
5_6142969729217726658-1.pdf
 
Contents lists available at ScienceDirectApplied Nursing R
Contents lists available at ScienceDirectApplied Nursing RContents lists available at ScienceDirectApplied Nursing R
Contents lists available at ScienceDirectApplied Nursing R
 
EBP-NPWT-G8-Faisal.pptx
EBP-NPWT-G8-Faisal.pptxEBP-NPWT-G8-Faisal.pptx
EBP-NPWT-G8-Faisal.pptx
 
Webinar: Defeating Superbugs: Hospitals on the Front Lines
Webinar: Defeating Superbugs: Hospitals on the Front Lines Webinar: Defeating Superbugs: Hospitals on the Front Lines
Webinar: Defeating Superbugs: Hospitals on the Front Lines
 
Healthcare transition.pptx
Healthcare transition.pptxHealthcare transition.pptx
Healthcare transition.pptx
 
Fletcher et al-2013-pediatric_blood_&amp;_cancer
Fletcher et al-2013-pediatric_blood_&amp;_cancerFletcher et al-2013-pediatric_blood_&amp;_cancer
Fletcher et al-2013-pediatric_blood_&amp;_cancer
 
Fletcher et al-2013-pediatric_blood_&amp;_cancer
Fletcher et al-2013-pediatric_blood_&amp;_cancerFletcher et al-2013-pediatric_blood_&amp;_cancer
Fletcher et al-2013-pediatric_blood_&amp;_cancer
 
Goal directed resuscitation for patients
Goal directed resuscitation for patientsGoal directed resuscitation for patients
Goal directed resuscitation for patients
 
NYP EBP Cohort 8 Under Pressure
NYP EBP Cohort 8 Under PressureNYP EBP Cohort 8 Under Pressure
NYP EBP Cohort 8 Under Pressure
 
20150300.0 00014
20150300.0 0001420150300.0 00014
20150300.0 00014
 
Quality indicators for prevention and management of pressure ulcers
Quality indicators for prevention and management of pressure ulcersQuality indicators for prevention and management of pressure ulcers
Quality indicators for prevention and management of pressure ulcers
 
main.pdf
main.pdfmain.pdf
main.pdf
 
Quality in Critical Care_١١٣١٠١.pptx
Quality in Critical Care_١١٣١٠١.pptxQuality in Critical Care_١١٣١٠١.pptx
Quality in Critical Care_١١٣١٠١.pptx
 
Impactof en feeding protocols
Impactof en feeding protocolsImpactof en feeding protocols
Impactof en feeding protocols
 

More from M. Luisetto Pharm.D.Spec. Pharmacology

Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...
Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...
Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...M. Luisetto Pharm.D.Spec. Pharmacology
 
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...M. Luisetto Pharm.D.Spec. Pharmacology
 
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...M. Luisetto Pharm.D.Spec. Pharmacology
 
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...M. Luisetto Pharm.D.Spec. Pharmacology
 
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...M. Luisetto Pharm.D.Spec. Pharmacology
 
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docxJOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docxM. Luisetto Pharm.D.Spec. Pharmacology
 
Acceptance letter j. of forensic research OPAST - White paper on Covid- 19 a...
Acceptance letter j. of forensic research OPAST - White paper on  Covid- 19 a...Acceptance letter j. of forensic research OPAST - White paper on  Covid- 19 a...
Acceptance letter j. of forensic research OPAST - White paper on Covid- 19 a...M. Luisetto Pharm.D.Spec. Pharmacology
 
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...M. Luisetto Pharm.D.Spec. Pharmacology
 
WHITE PAPER - m RNA vaccine production Quality control- regulatory and toxic...
WHITE PAPER - m RNA vaccine production Quality control-  regulatory and toxic...WHITE PAPER - m RNA vaccine production Quality control-  regulatory and toxic...
WHITE PAPER - m RNA vaccine production Quality control- regulatory and toxic...M. Luisetto Pharm.D.Spec. Pharmacology
 
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...M. Luisetto Pharm.D.Spec. Pharmacology
 
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et al 202...
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et  al 202...MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et  al 202...
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et al 202...M. Luisetto Pharm.D.Spec. Pharmacology
 
ACCEPTATION LETTER SWJPS Review comment Form (swjps-1-107) Graphene and Deri...
ACCEPTATION LETTER SWJPS Review  comment Form (swjps-1-107) Graphene and Deri...ACCEPTATION LETTER SWJPS Review  comment Form (swjps-1-107) Graphene and Deri...
ACCEPTATION LETTER SWJPS Review comment Form (swjps-1-107) Graphene and Deri...M. Luisetto Pharm.D.Spec. Pharmacology
 
IMA 2022 Marijnskaya certificate GRAPHENE and DERIVATES chemico -physical ...
IMA  2022 Marijnskaya certificate GRAPHENE and  DERIVATES  chemico -physical ...IMA  2022 Marijnskaya certificate GRAPHENE and  DERIVATES  chemico -physical ...
IMA 2022 Marijnskaya certificate GRAPHENE and DERIVATES chemico -physical ...M. Luisetto Pharm.D.Spec. Pharmacology
 
EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
EDITORIAL  GRAPHENE and DERIVATES  CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...EDITORIAL  GRAPHENE and DERIVATES  CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...M. Luisetto Pharm.D.Spec. Pharmacology
 
Pdf Book -GRAPHENE and DERIVATES PHYSICO- CHEMICAL AND TOXICOLOGY properti...
Pdf Book -GRAPHENE and  DERIVATES  PHYSICO- CHEMICAL  AND TOXICOLOGY properti...Pdf Book -GRAPHENE and  DERIVATES  PHYSICO- CHEMICAL  AND TOXICOLOGY properti...
Pdf Book -GRAPHENE and DERIVATES PHYSICO- CHEMICAL AND TOXICOLOGY properti...M. Luisetto Pharm.D.Spec. Pharmacology
 
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...M. Luisetto Pharm.D.Spec. Pharmacology
 
Luisetto M ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022 GRA...
Luisetto M  ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022   GRA...Luisetto M  ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022   GRA...
Luisetto M ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022 GRA...M. Luisetto Pharm.D.Spec. Pharmacology
 

More from M. Luisetto Pharm.D.Spec. Pharmacology (20)

Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...
Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...
Acceptance letter 25052 (1)-2 SUDDEN CARDIAC DEATHS BEFORE - AFTER COVID -19 ...
 
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA  Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA
 
Mauro Luisetto Abstract Acceptance Letter.pdf
Mauro Luisetto Abstract Acceptance Letter.pdfMauro Luisetto Abstract Acceptance Letter.pdf
Mauro Luisetto Abstract Acceptance Letter.pdf
 
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA.pdf
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA.pdfTeoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA.pdf
Teoria del libro PLUS IMAGO- PHILOSOPHIA ET SCIENTIA.pdf
 
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
ICRJ-2-1071 Monoliths in the mRNA Vaccine Purification Process the Silica Res...
 
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
Current Research in Vaccines ACCEPTATION LETTER m R.N.A. PURIFICATIONS PROCES...
 
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
Graphene Derivates Carbon Products and Separation Properties : the M R.N.A. P...
 
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
m R.N.A. Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and ...
 
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docxJOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
JOURNAL OF FORENSIC PATHOLOGY ARTICLE IN PRESS LUISETTO ET AL 2022.docx
 
Acceptance letter j. of forensic research OPAST - White paper on Covid- 19 a...
Acceptance letter j. of forensic research OPAST - White paper on  Covid- 19 a...Acceptance letter j. of forensic research OPAST - White paper on  Covid- 19 a...
Acceptance letter j. of forensic research OPAST - White paper on Covid- 19 a...
 
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
Raman (Rs) Spettroscopy for Biopharmaceutical Quality Control and Pat Raw Mat...
 
WHITE PAPER - m RNA vaccine production Quality control- regulatory and toxic...
WHITE PAPER - m RNA vaccine production Quality control-  regulatory and toxic...WHITE PAPER - m RNA vaccine production Quality control-  regulatory and toxic...
WHITE PAPER - m RNA vaccine production Quality control- regulatory and toxic...
 
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
SWJPS-Graphene and Derivates Physico-Chemical and Toxicology Properties in th...
 
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et al 202...
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et  al 202...MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et  al 202...
MENTAL ENERGY cover image by ALESSANDRA FALEGGI-Authors luisetto M et al 202...
 
ACCEPTATION LETTER SWJPS Review comment Form (swjps-1-107) Graphene and Deri...
ACCEPTATION LETTER SWJPS Review  comment Form (swjps-1-107) Graphene and Deri...ACCEPTATION LETTER SWJPS Review  comment Form (swjps-1-107) Graphene and Deri...
ACCEPTATION LETTER SWJPS Review comment Form (swjps-1-107) Graphene and Deri...
 
IMA 2022 Marijnskaya certificate GRAPHENE and DERIVATES chemico -physical ...
IMA  2022 Marijnskaya certificate GRAPHENE and  DERIVATES  chemico -physical ...IMA  2022 Marijnskaya certificate GRAPHENE and  DERIVATES  chemico -physical ...
IMA 2022 Marijnskaya certificate GRAPHENE and DERIVATES chemico -physical ...
 
EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
EDITORIAL  GRAPHENE and DERIVATES  CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...EDITORIAL  GRAPHENE and DERIVATES  CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
EDITORIAL GRAPHENE and DERIVATES CHEMICO-PHYSICAL AND TOXICOLOGICAL PROPERT...
 
Pdf Book -GRAPHENE and DERIVATES PHYSICO- CHEMICAL AND TOXICOLOGY properti...
Pdf Book -GRAPHENE and  DERIVATES  PHYSICO- CHEMICAL  AND TOXICOLOGY properti...Pdf Book -GRAPHENE and  DERIVATES  PHYSICO- CHEMICAL  AND TOXICOLOGY properti...
Pdf Book -GRAPHENE and DERIVATES PHYSICO- CHEMICAL AND TOXICOLOGY properti...
 
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
Sars-cov2 Spike protein and derivates toxicology :fertility and teratogen eva...
 
Luisetto M ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022 GRA...
Luisetto M  ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022   GRA...Luisetto M  ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022   GRA...
Luisetto M ND agosto 2022 estratto in lingua italiana pubb. 05-08-2022 GRA...
 

Recently uploaded

CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls ServiceMiss joya
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliRewAs ALI
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Servicevidya singh
 
Call Girls Service Navi Mumbai Samaira 8617697112 Independent Escort Service ...
Call Girls Service Navi Mumbai Samaira 8617697112 Independent Escort Service ...Call Girls Service Navi Mumbai Samaira 8617697112 Independent Escort Service ...
Call Girls Service Navi Mumbai Samaira 8617697112 Independent Escort Service ...Call girls in Ahmedabad High profile
 
Call Girls Yelahanka Bangalore 📲 9907093804 💞 Full Night Enjoy
Call Girls Yelahanka Bangalore 📲 9907093804 💞 Full Night EnjoyCall Girls Yelahanka Bangalore 📲 9907093804 💞 Full Night Enjoy
Call Girls Yelahanka Bangalore 📲 9907093804 💞 Full Night Enjoynarwatsonia7
 
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safenarwatsonia7
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...CALL GIRLS
 
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...Miss joya
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Deliverynehamumbai
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.MiadAlsulami
 
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safenarwatsonia7
 
Call Girls Service Bellary Road Just Call 7001305949 Enjoy College Girls Service
Call Girls Service Bellary Road Just Call 7001305949 Enjoy College Girls ServiceCall Girls Service Bellary Road Just Call 7001305949 Enjoy College Girls Service
Call Girls Service Bellary Road Just Call 7001305949 Enjoy College Girls Servicenarwatsonia7
 
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...Taniya Sharma
 
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy GirlsCall Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy Girlsnehamumbai
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...Garima Khatri
 
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...astropune
 
High Profile Call Girls Coimbatore Saanvi☎️ 8250192130 Independent Escort Se...
High Profile Call Girls Coimbatore Saanvi☎️  8250192130 Independent Escort Se...High Profile Call Girls Coimbatore Saanvi☎️  8250192130 Independent Escort Se...
High Profile Call Girls Coimbatore Saanvi☎️ 8250192130 Independent Escort Se...narwatsonia7
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escortsvidya singh
 

Recently uploaded (20)

CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls ServiceCALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune)  Girls Service
CALL ON ➥9907093804 🔝 Call Girls Hadapsar ( Pune) Girls Service
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas Ali
 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
 
Call Girls Service Navi Mumbai Samaira 8617697112 Independent Escort Service ...
Call Girls Service Navi Mumbai Samaira 8617697112 Independent Escort Service ...Call Girls Service Navi Mumbai Samaira 8617697112 Independent Escort Service ...
Call Girls Service Navi Mumbai Samaira 8617697112 Independent Escort Service ...
 
Call Girls Yelahanka Bangalore 📲 9907093804 💞 Full Night Enjoy
Call Girls Yelahanka Bangalore 📲 9907093804 💞 Full Night EnjoyCall Girls Yelahanka Bangalore 📲 9907093804 💞 Full Night Enjoy
Call Girls Yelahanka Bangalore 📲 9907093804 💞 Full Night Enjoy
 
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
 
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
 
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Servicesauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
 
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
 
Call Girls Service Bellary Road Just Call 7001305949 Enjoy College Girls Service
Call Girls Service Bellary Road Just Call 7001305949 Enjoy College Girls ServiceCall Girls Service Bellary Road Just Call 7001305949 Enjoy College Girls Service
Call Girls Service Bellary Road Just Call 7001305949 Enjoy College Girls Service
 
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
 
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy GirlsCall Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
Call Girls In Andheri East Call 9920874524 Book Hot And Sexy Girls
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
 
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCREscort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
 
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
 
High Profile Call Girls Coimbatore Saanvi☎️ 8250192130 Independent Escort Se...
High Profile Call Girls Coimbatore Saanvi☎️  8250192130 Independent Escort Se...High Profile Call Girls Coimbatore Saanvi☎️  8250192130 Independent Escort Se...
High Profile Call Girls Coimbatore Saanvi☎️ 8250192130 Independent Escort Se...
 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
 

Establishing a Pharmaceutical Care Model and Evaluating Drug-Related Problems in Renal Transplant Patients

  • 1. EstablishingandEvaluatingaPharmaceutical Care inRenal TransplantationClinicandthe Integrated PharmaCloudService forPharmacistProfessionalPerformance Authors Wang,Hue-Yu http://www.airitilibrary.com/Publication/alDetailedMesh1?DocID=U0011-2411201600293900 KMUIR > College of Pharmacy > Graduate Institute of Pharmaceutical Sciences >Theses > Item 310902000/40198 References 87 unitiesandresponsibilitiesinpharmaceutical care.AmericanJournal of Hospital Pharmacy.1990;47: 533-543. 譚延輝.藥事照護在台灣.藥學雜誌.2011;27:42-45. KohnLT, editor.AcademicHealthCenters:LeadingChange inthe 21st Century.Washington(DC):National AcademiesPress(US);2004. EXECUTIVE SUMMARY. 2004; http://www.ncbi.nlm.nih.gov/books/NBK221671/.AccessedNov11, 2015 gnaG, Nili-AhmadabadiB.PharmacistCognitive Service andPharmaceutical Care:Todayand TomorrowOutlook.UKJournal of Pharmaceutical andBiosciences.2015;3:67-72. Model. 2008 ver.2;http://www.pharmacist.com/sites/default/files/files/core_elements_of_an_mtm_practice.pdf. ----------------------------------------------------------------------------------------------------------------------------------------------- -- Background:To preventdrug-relatedproblemsinadvance andthusensure patientsafetyiscloselyrelated to properpharmaceutical care andeffective model forpharmaceutical care.Atthe moment,OPD pharmaceutical consultationisprovidedaccordingtophysicians’ordersandpatients’need.However, proactive pharmaceutical care istobe initiatedandofferedbypharmaciststointerview face-to-face the patients,discoverdrug-relatedproblems,provide withtherapyrecommendations,andinstructthe patients howto take the medicinesproperly.Togetherwithwellrecordsof pharmaceutical care anddocumentsfor drug-relatedproblems,greaterprofessionalismof pharmacistswouldbe demonstrated. Objective:The studyaimstoestablishamodel of proactive pharmaceutical care basedondataon the NHI PharmaCloudandhastwo objectives.First,toevaluate if persistentinfectiousdiarrheaisarisk factorfor deteriorationof renal functioninkidneytransplantrecipients.Secondly,toanalyze the dataregarding the prevalence andtypesof drug-relatedproblems(DRPs) andthe recommendationsforoptimizingmedication providedbyclinical pharmacistsaftertwostages(Firststage (FS):pharmacistsreviewedthe datareal-time and recordedthe DRPs;Secondstage (SS):pharmacistsreviewedandevaluatedthe pre-downloaded patientprescriptiondataandrecordedall the DRPs) of implementationof NHIPharmaCloudSystem. Methods:A cross-sectionalprospectivestudywasconductedata medical centerinSouthernTaiwan.In the
  • 2. firstpart of the study,a retrospective andobservational studywasconductedusingHyperinDatabase of the hospital.Patientswerecollectedaccordingtodiagnosesof diarrhea,diarrheaperiod≥3 days,use (or not) of antibioticagents.Studentt-testsorANOVA were usedtoverifythe correlationamongthe serum creatinine changesanddiarrheacauses,diarrheaperiods(continuousvariables).Inthe secondpartof the study,data are presentedasmeanswithstandarddeviationsforcontinuousvariables andnumberswithfor categorical variables.Drug-relatedproblemswereprobedandencodedwithAABBCCandrecorded accordingto PCNE DRP v6.2 guideline (Pharmaceutical Care NetworkEurope WorkinggrouponDRPs). Wilcoxonsigned-ranktestforcontinuousvariablesandPearson'sChi-square testorFisher'sexacttestfor categorical variableswasusedtocompare the differencesbetweentwogroups.The logisticregressionwas usedto estimate the associationbetweeneachdrug-relatedproblemsandstages.The multivariable logistic regressioncalculatedthe oddsratios(ORs) and95% confidence intervals(CIs)afteradjustingpotential confoundingfactors.Significance wassetatp< 0.05. All analyseswere presentedusingStatisticalAnalysis System(SAS) statisticalsoftware (version9.4;SASInstitute,Inc,Cary,NC). Resultsanddiscussion:The preliminaryresultsof the firstpartof the studyrevealedthatinkidney transplantrecipients,patientswithinfectiousdiarrheademonstratedalargermeanserumcreatinine (Scr) change than those withnon-infectiousdiarrhea(0.31±0.52 vs.0.1±0.27), and whentheirdiarrheapersisted for more than 10 days,a significantlargermeanserumcreatinine change wouldbe observed(0.53±0.55 vs. 0.05±0.22; comparedwiththose withdiarrheaperiodof <10 days,p=0.0018), showingthatthe irreversible kidneyallograftfunctionchange wasassociatedwithbothpersisteddiarrheaandinfectiousdiarrhea. Besides,the immunosuppressive combinationof tacrolimus(TAC) andmycophenolate mofitil (MMF) might be associatedwithanincreasedriskof noninfectiousdiarrhea. The resultsof the secondpart of the studyrevealedthat“Treatmenteffectiveness”(Untreatedindication; 50.0%) was the mainprobleminthe FS groupand “Patient”(Patientforgetstouse/take drug;55.0%) inthe SS group.Furtheranalysesof logisticregressionsrevealedthatpatientsinthe SSgrouphad a 2.7 timesof riskto receive “Unnecessarydrug-treatment(P3.2)”than theydidinFS group(OR 2.7; p<0.0001) indicating that the prescriptiondatadownloadedinbatchesfromthe PharmaCloudSystemcouldbe helpful for clinical pharmaciststoidentifyDRPsmore efficientlywithsignificantclinicalbenefits.Onclassificationof the drug-relatedproblems,“Treatmenteffectiveness”(41.3%) wasthe mostfrequentlyseenprobleminthe FS groupand “Treatmentcost” (48.3%) in the SS group,and furtheranalysesdemonstratedthat “Unnecessarydrugtreatment”wasthe mainproblemforall patients.Onthe cause of the problems,“Drug selection”became the maincause forall the problems. Thisstudydemonstratedthatthe PharmaCloudSystemallowedprescriptioninformationof patientstobe sharedacross hospitalsandenabledpharmacistsandphysicianstoreview andevaluatemedicationsin advance.The potential problemsof “Unnecessarydrugtreatment”andthe treatmentcostderivedfrom that wouldbe resolvedefficiently. Conclusion:Ourstudybringsnewdatainthe directionshowingthatinfectiousdiarrheadoesmore damagesto renal functionthannon-infectiousonesinkidneytransplantrecipients,especiallywhenthe diarrheapersistsformore than10 days.Our studyalso demonstratedthathigherefficiencyof the use of the proactive model of pharmaceutical care waseasilyachievedtopreventand/orsolvedrug-related problemsinadvance withPharmaCloudsystemessedNov11,2015